Delivery Order SPE2DB22D3016-SPE2DB24FBGN3

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $8.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,024 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The award is for the supply of 4565483193 MESTINON 180 MG TIMESPAN UU 30S pharmaceutical products. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the federal government, and this award is likely part of a larger Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,691.14, is for the delivery of MESTINON 180 MG TIMESPAN UU 30S, a prescription medication. The contract has an ultimate completion date of December 3, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,627.76 firm fixed-price delivery order is for the supply of 4566963200 units of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,740.10, is for the delivery of Mestinon 180 mg Timespan medication. It is a firm fixed-price delivery order contract with a completion date of February 26, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award, valued at $3,732.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of February 28, 2025. It is not designated with a set-aside requirement, indicating open competition....
This federal contract award, valued at $8,426.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,566,759,628 units of MESTINON 180 MG TIMESPAN UU 30S, with a completion date of December 19, 2024. The contract is a firm fixed-price, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $12,756.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 27, 2025. The contract covers the procurement of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,395.46 firm fixed-price delivery order is for the supply of MESTINON 180 MG TIMESPAN UU 30S, a medication used to treat certain neurological conditions. The award has an ultimate completion date of January 28, 2025 and is not associated with a set-aside designation. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MESTINON 60 MG TABLET 100S. The award has a total ceiling value of $3,536.17 and a completion date of December 20, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $1,587.93, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award supports the delivery of 4566859730 MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product, to the DLA. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 8, 2025. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has been awarded this...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBGN3
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $8,831.25 contract is for the supply of 180 mg MESTINON TIMESPAN medication, with a completion date of September 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of prescription drugs and medical supplies to military treatment facilities, veterans' hospitals, and other government healthcare providers. This contract is not set aside for any particular business category. Amerisourcebergen holds several large Indefinite Delivery Contracts with the DLA and other agencies, valued up to $999,999,999 and $750,000, respectively, for delivering a comprehensive portfolio of essential pharmaceutical and medical commodities to support federal healthcare programs and operations.

Generated 12/11/24, 9:28 AM